Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8889 |
High Similarity |
NPD7266 |
Discontinued |
0.8528 |
High Similarity |
NPD7685 |
Pre-registration |
0.8431 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8344 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8293 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8293 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8282 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8282 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8278 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8253 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.817 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD37 |
Approved |
0.8084 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8063 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8063 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8063 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8036 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8024 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7972 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7875 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7765 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7759 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7716 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7674 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7674 |
Intermediate Similarity |
NPD8313 |
Approved |
0.767 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7616 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7616 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7576 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7545 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7516 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7466 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7434 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7418 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7375 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7338 |
Intermediate Similarity |
NPD447 |
Suspended |
0.733 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD228 |
Approved |
0.7303 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7294 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7285 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7258 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7239 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD5494 |
Approved |
0.717 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7112 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7091 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7091 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7081 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7075 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7068 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7063 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7051 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7017 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7012 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD5647 |
Approved |
0.6984 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6984 |
Remote Similarity |
NPD7697 |
Approved |
0.6984 |
Remote Similarity |
NPD7698 |
Approved |
0.6981 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.697 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6964 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6957 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD1608 |
Approved |
0.6954 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD5242 |
Approved |
0.6948 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6947 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6947 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD3226 |
Approved |
0.6943 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD2438 |
Suspended |
0.6937 |
Remote Similarity |
NPD6099 |
Approved |
0.6937 |
Remote Similarity |
NPD6100 |
Approved |
0.6933 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6928 |
Remote Similarity |
NPD2797 |
Approved |
0.6927 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD3268 |
Approved |
0.6909 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6908 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6907 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6907 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6903 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6902 |
Remote Similarity |
NPD7296 |
Approved |
0.6901 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD7843 |
Approved |
0.6894 |
Remote Similarity |
NPD5763 |
Approved |
0.6894 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6894 |
Remote Similarity |
NPD5762 |
Approved |
0.6887 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6887 |
Remote Similarity |
NPD1535 |
Discovery |
0.6875 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6871 |
Remote Similarity |
NPD7157 |
Approved |
0.6867 |
Remote Similarity |
NPD1778 |
Approved |
0.6867 |
Remote Similarity |
NPD6273 |
Approved |
0.6863 |
Remote Similarity |
NPD3225 |
Approved |
0.686 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD8319 |
Approved |
0.6859 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6849 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6846 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6845 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6842 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6839
|
Remote Similarity |
NPD3018 |
Phase 2 |